These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18797080)

  • 1. Nimesulide-induced, multifocal, urticarial fixed drug eruption confirmed by oral provocation test.
    Rallis E; Stavropoulou E; Paraskevopoulos I
    Indian J Dermatol Venereol Leprol; 2008; 74(4):403-4. PubMed ID: 18797080
    [No Abstract]   [Full Text] [Related]  

  • 2. Fixed drug eruption to nimesulide: an exuberant presentation confirmed by patch testing.
    Marques LP; Villarinho ALCF; Melo MDGM; Torre MGS
    An Bras Dermatol; 2018 Jun; 93(3):470-472. PubMed ID: 29924254
    [No Abstract]   [Full Text] [Related]  

  • 3. [Allergic vasculitis following ingestion of celecoxib?].
    Gscheidel D; Daspet MK; Le Coz CJ; Lipsker D
    Hautarzt; 2002 Jul; 53(7):488-91. PubMed ID: 12219273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lithium poisoning and the use of nimesulide].
    Bocchia M; Bertola G; Morganti D; Toscano M; Colombo E
    Recenti Prog Med; 2001; 92(7-8):462. PubMed ID: 11475788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute low back pain with the COX-2-selective anti-inflammatory drug nimesulide: results of a randomized, double-blind comparative trial versus ibuprofen.
    Pohjolainen T; Jekunen A; Autio L; Vuorela H
    Spine (Phila Pa 1976); 2000 Jun; 25(12):1579-85. PubMed ID: 10851109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe ductal constriction in the third-trimester fetus following maternal self-medication with nimesulide.
    Paladini D; Marasini M; Volpe P
    Ultrasound Obstet Gynecol; 2005 Apr; 25(4):357-61. PubMed ID: 15791693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fixed drug eruption to rofecoxib with cross-reactivity to sulfonamides.
    Kaur C; Sarkar R; Kanwar AJ
    Dermatology; 2001; 203(4):351. PubMed ID: 11752830
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral and intravenous administration of nimesulide in the horse: rational dosage regimen from pharmacokinetic and pharmacodynamic data.
    Villa R; Cagnardi P; Belloli C; Zonca A; Zizzadoro C; Ferro E; Carli S
    Equine Vet J; 2007 Mar; 39(2):136-42. PubMed ID: 17378442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pseudoporphyria and coxib].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2006 Feb; 133(2):213. PubMed ID: 16508618
    [No Abstract]   [Full Text] [Related]  

  • 11. Extensive fixed drug eruption to nimesulide with cross-sensitivity to sulfonamides in a child.
    Sarkar R; Kaur C; Kanwar AJ
    Pediatr Dermatol; 2002; 19(6):553-4. PubMed ID: 12437563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute generalized exanthematic pustulosis: a case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far.
    Goeschke B; Braathen LR
    Dermatology; 2004; 209(1):53-6. PubMed ID: 15237269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nimesulide-induced fixed drug eruption.
    Malheiro D; Cadinha S; Rodrigues J; Vaz M; Castel-Branco MG
    Allergol Immunopathol (Madr); 2005; 33(5):285-7. PubMed ID: 16287549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocal fixed drug eruption due to celecoxib.
    Bellini V; Stingeni L; Lisi P
    Dermatitis; 2009; 20(3):174-6. PubMed ID: 19470306
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxic epidermal necrolysis due to administration of celecoxib (Celebrex).
    Giglio P
    South Med J; 2003 Mar; 96(3):320-1. PubMed ID: 12659372
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute generalized exanthematous pustulosis induced by nimesulide.
    Teixeira M; Silva E; Selores M
    Dermatol Online J; 2006 Oct; 12(6):20. PubMed ID: 17083900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive lesional patch tests in fixed drug eruptions from nimesulide.
    Cordeiro MR; Gonçalo M; Fernandes B; Oliveira H; Figueiredo A
    Contact Dermatitis; 2000 Nov; 43(5):307. PubMed ID: 11016675
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of celecoxib in individuals allergic to sulfonamide: a pilot study.
    Shapiro LE; Knowles SR; Weber E; Neuman MG; Shear NH
    Drug Saf; 2003; 26(3):187-95. PubMed ID: 12580647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can a cyclo-oxygenase type-2 selective tocolytic agent avoid the fetal side effects of indomethacin?
    Locatelli A; Vergani P; Bellini P; Strobelt N; Ghidini A
    BJOG; 2001 Mar; 108(3):325-6. PubMed ID: 11281476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is concern about cardiovascular events with the new coxib class of drugs justified?
    Schnitzer TJ
    Medscape Womens Health; 2001 Oct; 6(5):8. PubMed ID: 11698930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.